Literature DB >> 22846081

Maslinic acid protects against isoproterenol-induced cardiotoxicity in albino Wistar rats.

Althaf Hussain Shaik1, S N Rasool, M Abdul Kareem, G Saayi Krushna, P Mohammad Akhtar, Kodidhela Lakshmi Devi.   

Abstract

The present study aimed to evaluate the protective effect of maslinic acid (MA) on body weight, heart weight, lipids, lipoproteins, lipid peroxidation (LPO), cardiac marker enzymes, and paraoxonase (PON) in normal control and isoproterenol (ISO)-induced myocardial infarcted albino Wistar rats. After treatment with MA (15 mg/kg) for 7 days, myocardial infarction was induced by subcutaneous injection of ISO (85 mg/kg) for two consecutive days. ISO caused a considerable decrease in body weight and increased the heart weight. The concentrations of total cholesterol, triglycerides, very low-density lipoprotein-cholesterol, and low-density lipoprotein-cholesterol were higher, whereas that of high-density lipoprotein-cholesterol was lower, in the serum of ISO-administered rats. The activities of the cardiac marker enzymes creatine kinase, alanine transaminase, aspartate transaminase, and γ-glutamyl transferase and levels of malondialdehyde were elevated in the serum of ISO-treated rats. ISO-administered rats also exhibited a decline in the activity of PON. Pretreatment of rats with MA reduced the effects of ISO on all parameters tested. This is the first report of the protective effect of MA on ISO-induced cardiotoxicity and of an association between PON status and MA supplementation. The observed cardioprotective effects may be due to the antihyperlipidemic potential of MA, inhibition of LPO, and antioxidant activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22846081     DOI: 10.1089/jmf.2012.2191

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  7 in total

Review 1.  Pentacyclic Triterpene Bioavailability: An Overview of In Vitro and In Vivo Studies.

Authors:  Niege A J C Furtado; Laetitia Pirson; Hélène Edelberg; Lisa M Miranda; Cristina Loira-Pastoriza; Véronique Preat; Yvan Larondelle; Christelle M André
Journal:  Molecules       Date:  2017-03-04       Impact factor: 4.411

2.  Analysis of maslinic acid and gallic acid compounds as xanthine oxidase inhibitors in isoprenaline administered myocardial necrotic rats.

Authors:  Althaf Hussain Shaik; Shajidha Ruksar Shaik; Abdul Saheer Shaik; Ali Daoud; Manoharadas Salim; Lakshmi Devi Kodidhela
Journal:  Saudi J Biol Sci       Date:  2021-02-10       Impact factor: 4.219

3.  Phytochemicals: "A Small Defensive Advantage for Plants and Fungi; a Great Remedy for the Health of Mankind".

Authors:  José A Lupiáñez; Eva E Rufino-Palomares
Journal:  Molecules       Date:  2021-10-12       Impact factor: 4.411

4.  Olive Pomace Oil versus High Oleic Sunflower Oil and Sunflower Oil: A Comparative Study in Healthy and Cardiovascular Risk Humans.

Authors:  Susana González-Rámila; Raquel Mateos; Joaquín García-Cordero; Miguel A Seguido; Laura Bravo-Clemente; Beatriz Sarriá
Journal:  Foods       Date:  2022-07-22

5.  Maslinic acid-enriched diet decreases intestinal tumorigenesis in Apc(Min/+) mice through transcriptomic and metabolomic reprogramming.

Authors:  Susana Sánchez-Tena; Fernando J Reyes-Zurita; Santiago Díaz-Moralli; Maria Pilar Vinardell; Michelle Reed; Francisco García-García; Joaquín Dopazo; José A Lupiáñez; Ulrich Günther; Marta Cascante
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

Review 6.  Mechanistic Perspectives of Maslinic Acid in Targeting Inflammation.

Authors:  Wei Hsum Yap; Yang Mooi Lim
Journal:  Biochem Res Int       Date:  2015-09-27

7.  Terminalia pallida fruit ethanolic extract ameliorates lipids, lipoproteins, lipid metabolism marker enzymes and paraoxonase in isoproterenol-induced myocardial infarcted rats.

Authors:  Althaf Hussain Shaik; Nayab Rasool Shaik; Abdul Kareem Mohammed; Suliman Yousef Al Omar; Altaf Mohammad; Talal Abdulaziz Mohaya; Lakshmi Devi Kodidhela
Journal:  Saudi J Biol Sci       Date:  2017-11-09       Impact factor: 4.219

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.